Review
doi: 10.3949/ccjm.73.4.390.
Do thiazolidinediones cause heart failure? A critical review
Affiliations
- PMID: 16610400
- DOI: 10.3949/ccjm.73.4.390
Item in Clipboard
Review
Do thiazolidinediones cause heart failure? A critical review
Cleve Clin J Med.
2006 Apr.
Free article
Erratum in
- Cleve Clin J Med. 2006 Jun;73(6):588
Abstract
Concern has been raised about whether the fluid retention caused by thiazolidinediones (TZDs, ie, rosiglitazone and pioglitazone) can cause or exacerbate congestive heart failure. Although fluid retention is a worrisome side effect of TZDs, current evidence does not link fluid retention caused by TZDs with worsening heart function. TZDs have many benefits for patients with diabetes and can even be used cautiously in patients with mild heart failure, with careful monitoring of volume status.
Comment in
-
Thiazolidinediones and heart failure.Cleve Clin J Med. 2006 Jun;73(6):587; author reply 587-8. doi: 10.3949/ccjm.73.6.587. Cleve Clin J Med. 2006. PMID: 16784160 No abstract available.
Similar articles
-
[Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials].Rev Med Suisse. 2007 Aug 29;3(122):1876, 1878-83. Rev Med Suisse. 2007. PMID: 17896661 Review. French.
-
Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?Diab Vasc Dis Res. 2005 May;2(2):61-6. doi: 10.3132/dvdr.2005.010. Diab Vasc Dis Res. 2005. PMID: 16305060 Review.
-
Research profile. Is there a link? TZDs and congestive heart failure. Andrew Karter, PhD.Diabetes Forecast. 2004 Jun;57(6):98-100. Diabetes Forecast. 2004. PMID: 15195634 No abstract available.
-
Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure.Am J Health Syst Pharm. 2007 May 1;64(9):931-6. doi: 10.2146/ajhp060446. Am J Health Syst Pharm. 2007. PMID: 17468147 Review.
-
Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits.Cardiol Rev. 2009 May-Jun;17(3):132-5. doi: 10.1097/CRD.0b013e31819faab2. Cardiol Rev. 2009. PMID: 19384087 Review.
Cited by
-
Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Int J Hepatol. 2012;2012:950693. doi: 10.1155/2012/950693. Epub 2012 Dec 9. Int J Hepatol. 2012. PMID: 23304532 Free PMC article.
-
Glycemic control and treatment patterns in patients with heart failure.Curr Cardiol Rep. 2007 May;9(3):242-7. doi: 10.1007/BF02938357. Curr Cardiol Rep. 2007. PMID: 17470338 Review.
-
The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria.PPAR Res. 2012;2012:513865. doi: 10.1155/2012/513865. Epub 2011 Jun 9. PPAR Res. 2012. PMID: 21772838 Free PMC article.
-
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.Eur Heart J. 2010 Apr;31(7):824-31. doi: 10.1093/eurheartj/ehp604. Epub 2010 Jan 29. Eur Heart J. 2010. PMID: 20118174 Free PMC article. Clinical Trial.
-
Thiazolidinediones and cardiovascular risk - a question of balance.Curr Cardiol Rev. 2009 Aug;5(3):155-65. doi: 10.2174/157340309788970333. Curr Cardiol Rev. 2009. PMID: 20676274 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
